Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT00708812

Completed

Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer
NCT00511849

Completed

Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors

Neoplasms
NCT00222469

Completed

Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer
NCT00389129

Completed

Danish Aspirin Resistance Trial - Pilot Study

Drug Resistance
NCT00150657

Unknown

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

Non-Small Cell Lung Cancer
NCT07011134

Completed

Timing of Aminophylline and Recovery in Pediatric Ambulatory Surgery (ELEAR-PAP)

Pediatric Anesthesia | Ambulatory Surgery | Postoperative Recovery
NCT07484503

Recruiting

Effectiveness of Combined Kinesiotapping and Core Stability Exercises in SIJ Dysfunction

Sacroiliac Dysfunction
NCT07142941

Not yet recruiting

Exercise and/or HMB in Older Diabetes With Low Muscle Mass

Diabetes | Low Muscle Mass
NCT06977503

Recruiting

Electrotherapy Stimulation Together With Life Coaching for the Support of Burnout Symptoms in Healthcare Workers

Psychiatric Disorder
NCT06593470

Not yet recruiting

Mindfulness-Based Substance Use Prevention (MINDS-UP) (MINDS-UP)

Substance Use
NCT06073717

Active, not recruiting

Motor-cognitive Training Effects on Cognition in Breast Cancer Survivors: the BRAINonFIT Study (BRAINonFIT). (BRAINonFIT)

Cognitive Impairment | Executive Dysfunction | Breast Cancer Survivors
NCT07148557

Active, not recruiting

A Study of Single Dose of LP-003 in Adolescent Subjects

Allergic Diseases
NCT06827353

Recruiting

Niraparib Versus Bevacizumab As Maintenance Therapy in Patients with De Novo Ovarian Cancer Without Homologous Recombination Deficiency (OVNI-B)

Ovarian Carcinoma
NCT06611826

Not yet recruiting

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

Nasopharynx Cancer
NCT06540729

Recruiting

RC48 in Combination With AK104 and Bevacizumab in OCCC (DAB)

Ovary Cancer
NCT06441019

Not yet recruiting

Efficacy and Safety of HAIC in Combination With TQB2868 and Ramucirumab for Second-line Treatment of Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma，Bispecific Antibodies, HAIC, Ramucirumab
NCT06241235

Recruiting

Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma

Cervical Carcinoma
NCT05932472

Recruiting

Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial (ASPIRIN-C3)

Cardiovascular Diseases | Atherosclerosis | Drug Effect
NCT05247619

Recruiting

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Cervical Cancer
NCT04267978

Recruiting

Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

Glioblastoma, Recurrent | Lower Grade Glioma, Recurrent
NCT04121455

Active, not recruiting

Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients (GLORIA)

Glioblastoma
NCT03765619

Completed

Postoperative Aspirin and Ankle Fracture Healing

Ankle Fractures
NCT00961571

Terminated

Sunitinib and Capecitabine for First Line Colon Cancer

Metastatic Colorectal Cancer
NCT04730999

Completed

Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer (CeLEBrATE)

Small Cell Lung Cancer
NCT05295173

Completed

A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Acute Ischemic Stroke
NCT04149171

Completed

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage

Hemorrhagic Shock
NCT00805961

Completed

RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM

Glioblastoma Multiforme
NCT00049361

Completed

Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases

Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific
NCT00295503

Completed

Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma

Mesothelioma
NCT01978366

Terminated

Open Label Extension Study of HT-100 in Patients With DMD

Duchenne Muscular Dystrophy
NCT04382027

Completed

Pharmacokinetics of Omega-3 Monoglycerides

Healthy
NCT02978040

Completed

Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI. (FABOLUS-FASTER)

Coronary Artery Disease | STEMI - ST Elevation Myocardial Infarction
NCT01114555

Completed

Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma

Neuroblastoma
NCT01735071

Completed

Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer

Ovarian Epithelial Cancer Recurrent
NCT00727415

Completed

Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy (LLC0606)

Chronic Lymphocytic Leukemia
NCT01558167

Completed

A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia (CLL2P)

Chronic Lymphocytic Leukemia
NCT00890786

Completed

A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas

Diffuse Intrinsic Pontine Glioma | Newly Diagnosed High-Grade Gliomas
NCT00408070

Terminated

Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Stage 4 Cancer | Stage 3 Cancer
NCT00434642

Completed

A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma (OCEANS)

Ovarian Cancer
NCT00121446

Completed

Which Therapy for Acute Heart Attacks? (The WEST Study)

Myocardial Infarction
NCT00574769

Completed

Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer

Prostate Cancer
NCT02687854

Completed

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist (PIXI-F)

Atrial Fibrillation
NCT01019174

Completed

Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple Myeloma (MM_LEN_DEX_CY)

Multiple Myeloma
NCT01038635

Completed

5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

Leukemia
NCT01400646

Completed

A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers

Healthy
NCT00887575

Completed

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

Breast Cancer
NCT02411331

Unknown

Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci (Etha-LOCK)

Catheter Related Blood Stream Infections | Intravenous Drug Delivery Systems | Lock Solution | Central Venous Catheter Infection | Coagulase-negative Staphylococci Infection
NCT01649791

Terminated

Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia
NCT00920868

Completed

XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib (XAD)

Metastatic Colorectal Cancer | Solid Tumor
NCT00925769

Completed

ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer

Pancreatic Cancer

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations